期刊文献+

欣普贝生用于未足月胎膜早破引产临床观察 被引量:11

欣普贝生用于未足月胎膜早破引产临床观察
下载PDF
导出
摘要 目的:探讨欣普贝生用于未足月胎膜早破促宫颈成熟引产的临床效果及安全性。方法:选择200例孕35~36+6周单胎、头位、无宫缩的初产妇为实验组,使用欣普贝生一枚,横置于阴道后穹窿内;同期使用催产素静滴组作为对照组,对照组予5%葡萄糖500ml+缩宫素2.5单位静滴。观察宫颈成熟度,分娩方式、产后出血量以及新生儿情况。结果:用药后实验组宫颈成熟度明显增高,24h阴道分娩率明显增加,剖宫产率明显下降,差异有统计学意义(P<0.05);而产后出血量及新生儿窒息情况,两组比较差异无统计学意义(P>0.05)。结论:欣普贝生用于未足月胎膜早破引产疗效可靠,但在引产过程中需严密观察宫缩及胎心,减少不良反应的发生。 Objective:To exlore the clinical effects and safety of dinopmstone for cervical ripening and artificial labor in preterm prematurerup rupture of membranes. Methods :200 primipara at 35 to 36 + 6 weeks of gestation single birth, head presentation without uterine contraction were randomly divided into observation group and control group, 100 cases in each group. One piece of dJnoprostone was put into the vag4nal posteri or fornix of gravida in observe group, and Oxytocin 2.5 U added in 50 g·L^-1 glucose of 500 mL was used intravascularly in control group. The maternal cervical Bishop score, vaginal delivery rate, cesarean section rate postpartum hemorrhage, and neonatal asphyxia rate were compared between two groups. Results:The maternal cervical Bishop score of observe group were higher than those of control group ( P 〈 0.05 ) ,The vaginal delivery rate in 24 hours of observe group were higher than those of control group ( P 〈 0.05 ) ;The cesarean section rate of observe group was lower than that of control group ( P 〈 0.05 ). There were no significant difference in post partumhemorrhage and neonatal as phyxia rate between two groups ( P 〉 0. 05 ). Conclusion:Dinoprostone was effective and safe for cervical ripening and artificial labor in preterm prematurernp rupture of membranes, but we should observate fetal heart and uterine contraction carefully, in order to decrease the adverse reaction.
出处 《医学信息(中旬刊)》 2011年第2期659-660,共2页 Medical Information Operations Sciences Fascicule
关键词 欣普贝生 未足月胎膜早破 引产 Dinopmstone Preterm prematurerup rupture of membranes Rtificial labor
  • 相关文献

参考文献6

二级参考文献2

共引文献498

同被引文献78

  • 1陈美霞,方善红,黄月娇,韩颖,张金花.胎膜早破96例妊娠结局临床分析[J].现代生物医学进展,2011,11(S2):5083-5085. 被引量:6
  • 2时春艳,杨慧霞,谢翠英,董悦.妊娠期糖代谢异常对巨大儿发生率及其他相关问题的影响[J].中华围产医学杂志,2005,8(1):9-12. 被引量:90
  • 3左晶,费军伟,王毅,魏振彤.妊娠合并糖尿病对孕产妇及围生儿影响的临床分析[J].中国妇幼保健,2006,21(15):2063-2064. 被引量:24
  • 4ACOG Committee on Practice Bulletins-Obstetrics. ACOG prac- tice bulletin(No. 80): premature rupture of membranes: clinical management guidelines for obstetrician-gynecologists. Obstet Gy- necol,2007,109:1007-1019. 被引量:1
  • 5Kasdaglis T,Adamczak J,Rinehart B,et al. A randomized con-trailed trial of cervical ripening in patients with PROM using an intracervical balloon catheter and oxytocin versus dinoprostone. Am J Obstet Gynecol, 2007,197 : S 10-S111. 被引量:1
  • 6Chiong TP, Aishah DS,Zawiah OS. Concurrent dinoprostone and oxytocin for labor induction in term premature rupture of mem- branes: a randomized controlled trial. Obstet Gynecol,2009, 113:1059-1065. 被引量:1
  • 7Kunt C, Pektas MK, Gungor AN,et al. Randomized trial of vagi- nal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes. Taiwan J Obstet Gynecol, 2010, 49 : 57-61. 被引量:1
  • 8谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264. 被引量:857
  • 9金海萍,曹海华,杨慧雅,等.欣普贝生在宫颈低评分足月胎膜早破引产中的临床观察及护理[J].祝您健康·新医药,2012,3(1):40,46. 被引量:1
  • 10Lyrenas S, Clason I, Ulmasten U. Invivo controlled release ofPGE2 from a vaginal insert (0. 8 mm, 10mg) during induction oflabour[J]. BJOG, 2001, 108:169. 被引量:1

引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部